Showing results (61-70 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 12, 2026
Hepatocellular carcinoma in the immunotherapy Era: A SEER-based era comparison across the U.S. FDA transitionTian-Run Lv, Wei Huang, Rabia Zahid Bukhari, et al.
World Journal of Gastroenterology|December 31, 2008
Treatment of chronic proliferative cholangitis with c-myc shRNAFu-Yu Li, Nan-Sheng Cheng, Jing-Qiu Cheng, et al.
Journal of Gastroenterology and Hepatology|November 27, 2008
Proliferating cell nuclear antigen shRNA treatment attenuates chronic proliferative cholangitis in ratsFu-Yu Li, Nan-Sheng Cheng, Jing-Qiu Cheng, et al.
Biomolecules & Biomedicine|September 19, 2023
Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity score-matched analysisYa-Fei Hu, Wen-Jie Ma, Hai-Jie Hu, et al.
World Journal of Surgical Oncology|January 19, 2023
The influence of resection margin width in patients with intrahepatic cholangiocarcinoma: a meta-analysisYu-Shi Dai, Hai-Jie Hu, Tian-Run Lv, et al.
Frontiers in Surgery|January 23, 2023
The role of laparoscopic surgery in the surgical management of recurrent liver malignancies: A systematic review and meta-analysisTian-Run Lv, Hai-Jie Hu, Wen-Jie Ma, et al.
Asian Journal of Surgery|December 31, 2022
Should more aggressive surgical resection be considered in the treatment for Bismuth types I and II hilar cholangiocarcinoma? A meta-analysisYa-Fei Hu, Hai-Jie Hu, Tian-Run Lv, et al.
Asian Journal of Surgery|April 15, 2022
Comparison of clinicopathological characteristics of mucinous adenocarcinoma and conventional adenocarcinoma of gallbladderRui-Qi Zou, Hai-Jie Hu, Fei Liu, et al.
International Journal of Clinical and Experimental Medicine|June 12, 2015
Incidence and risk factors of chylous ascites after pancreatic resectionWu Pan, Chen Yang, Shen-Yang Cai, et al.
BMC Cancer|September 5, 2020
Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resectionJian Zhao, Wei Zhang, Jun Zhang, et al.
Pageof 14